This is the main conclusion of a large American study just published in Biology of Sex Differences, which analyzed literature data from more than 5,400 references to determine whether gender differences in pharmacokinetic parameters predict differences in the occurrence of adverse events in men and [...]
Agir pour le Cœur des Femmes is driven by a single ambition: to reduce cardiovascular disease in France. To achieve this, our priority actions aim to save the lives of 100,000 women by 2030: - The development of care paths structured around women's health, with multidisciplinary care involving [...]
It is estimated that 150,000 women of childbearing age in France have a cardiovascular disease. If these patients don’t receive appropriate care during pregnancy, the risk of complications for their children is 15 times higher and their risk of death is 100 times higher. Pregnancy is a true [...]